Fubini Ross bought DNA
June 11, 2026 · Form 4 insider transaction
Fubini Ross bought 25,000 shares of Ginkgo Bioworks Holdings, Inc., a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Footnotes
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.; In accordance with the Issuer's Amended and Restated Non-Employee Director Compensation Program, which became effective on June 11, 2026, the RSUs shall vest on the earlier of June 11, 2027 or the day immediately prior to the date of the next Annual Meeting occurring after the date of grant, in either case, subject to the Reporting Person continuing in service as a Non-Employee Director through such vesting date.